Jackson Square Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Sell
7,767
-9,199
-54% -$2.14M 0.27% 52
2026
Q1
$4.15M Buy
16,966
+11,691
+222% +$2.72M 0.87% 30
2025
Q4
$1.09M Buy
+5,275
New +$1.04M 0.22% 66
2023
Q1
Sell
-5,779
Closed -$1.02M 122
2022
Q4
$1.02M Buy
5,779
+116
+2% +$20K 0.48% 53
2022
Q3
$925K Sell
5,663
-40
-0.7% -$6.77K 0.45% 53
2022
Q2
$1.01M Buy
5,703
+2,752
+93% +$490K 0.43% 60
2022
Q1
$523K Buy
2,951
+64
+2% +$10.9K 0.16% 110
2021
Q4
$494K Sell
2,887
-38
-1% -$6.22K 0.14% 133
2021
Q3
$472K Sell
2,925
-18
-0.6% -$3.07K 0.15% 121
2021
Q2
$485K Hold
2,943
0.16% 112
2021
Q1
$484K Buy
2,943
+267
+10% +$43.2K 0.18% 105
2020
Q4
$421K Buy
2,676
+147
+6% +$21.7K 0.16% 98
2020
Q3
$377K Buy
2,529
+1,020
+68% +$151K 0.17% 84
2020
Q2
$212K Buy
1,509
+579
+62% +$84.4K 0.11% 109
2020
Q1
$122K Hold
930
0.09% 89
2019
Q4
$136K Buy
+930
New +$126K 0.08% 111

Other funds holding JNJ

Jackson Square Capital's JNJ Position: Q2 2026 in Review

Jackson Square Capital reduced its Johnson & Johnson (JNJ) stake by 54% in Q2 2026, selling an estimated $2.14M and leaving 7,767 shares worth $1.97M. The position accounts for 0.27% of the portfolio, ranked #52.

Jackson Square Capital first reported a position in JNJ in Q4 2019 and has held it in 16 quarters since. The position peaked at $4.15M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Jackson Square Capital held 7,767 shares of Johnson & Johnson worth $1.97M as of Q2 2026.
  • Jackson Square Capital sold 9,199 Johnson & Johnson shares in Q2 2026, an estimated $2.14M.
  • Johnson & Johnson made up 0.27% of Jackson Square Capital's portfolio in Q2 2026, its #52 holding.
  • Jackson Square Capital first reported a position in Johnson & Johnson in Q4 2019 and has held it in 16 quarters since.
  • Jackson Square Capital's Johnson & Johnson position peaked at $4.15M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.